#145: Mortality benefit of running less than 20 miles per week; label update for dabigatran; who gets published?; alcohol may trigger AF episodes; FDA advisors: approve Sapien TAVR for high-risk operable patients

Mortality benefit of running less than 20 miles per week; label update for dabigatran; who gets published?; alcohol may trigger AF episodes; FDA advisors: approve Sapien TAVR for high-risk operable patients

Source: Radio TheHeart.org - June 15, 2012 Category: Cardiology Authors: theheart.org Tags: This week in cardiology from heartwire Source Type: podcasts